cilazapril, anhydrous has been researched along with Myocardial Ischemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (90.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, M; Inoue, M; Kamada, T; Kitakaze, M; Komamura, K; Kosaka, H; Minamino, T; Mori, H; Node, K; Shinozaki, Y | 1 |
| Arabatzis, N; Dössegger, L; Nielsen, T; Preston, C | 1 |
| Bilsel, S; Dogan, N; Emerk, K; Erşahin, C; Haklar, G; Moini, H; Süngün, M; Yalçin, AS | 1 |
| Schneeweiss, A; Wiegand, V | 1 |
| Marmor, AT; Rettig-Stürmer, G | 1 |
| Becker, BF; Gerlach, E; Habazettl, H; Kupatt, C; Messmer, K; Weber, C; Zahler, S | 1 |
| Asanuma, H; Hori, M; Kitakaze, M; Kosaka, H; Kuzuya, T; Minamino, T; Node, K; Ueda, Y | 1 |
| Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
| Becker, BF; Kupatt, C; Zahler, S | 1 |
| Asahi, T; Oshiro, Y; Shimabukuro, M; Takasu, N; Yoshida, H | 1 |
2 review(s) available for cilazapril, anhydrous and Myocardial Ischemia
| Article | Year |
|---|---|
Heart failure therapy with cilazapril: an overview.
Topics: Cardiomyopathy, Dilated; Cilazapril; Digitalis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Myocardial Ischemia; Plants, Medicinal; Plants, Toxic | 1994 |
[Treatment of myocardial ischemia with reference to blood pressure values].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cilazapril; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension; Myocardial Ischemia | 1993 |
1 trial(s) available for cilazapril, anhydrous and Myocardial Ischemia
| Article | Year |
|---|---|
Heart failure therapy with cilazapril: an overview.
Topics: Cardiomyopathy, Dilated; Cilazapril; Digitalis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Myocardial Ischemia; Plants, Medicinal; Plants, Toxic | 1994 |
8 other study(ies) available for cilazapril, anhydrous and Myocardial Ischemia
| Article | Year |
|---|---|
Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cilazapril; Coronary Circulation; Dogs; Myocardial Ischemia; Nitric Oxide | 1995 |
Protective effects of cilazapril against free radical injury in myocardial ischaemia-reperfusion.
Topics: Animals; Cilazapril; Disease Models, Animal; Free Radical Scavengers; Free Radicals; Humans; Lipid Metabolism; Lipid Peroxidation; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Proteins; Rabbits | 1995 |
[Anti-ischemia effects of cilazapril in hypertensive patients, with simultaneous angina pectoris. Preliminary report of a pilot study].
Topics: Aged; Angina Pectoris; Cilazapril; Electrocardiography; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Pilot Projects | 1993 |
ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Adhesion; Cilazapril; Coronary Vessels; Flow Cytometry; Guinea Pigs; Macrophage-1 Antigen; Male; Microscopy, Fluorescence; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Perfusion | 1997 |
Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cilazapril; Coronary Circulation; Dogs; Imidazoles; Imidazolidines; Myocardial Ischemia; Nitric Oxide; Peptidyl-Dipeptidase A | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
ACE-inhibition attenuates cardiac cell damage and preserves release of NO in the postischemic heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide | 1999 |
Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Size; Cilazapril; Coronary Circulation; Hemodynamics; Hyperthyroidism; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Myocardium; Organ Size; Oxygen Consumption; Propranolol; Rats; Rats, Sprague-Dawley; Triiodothyronine | 2001 |